Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00290004

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: USC Norris Cancer Hospital Los Angeles, California, United States

Scripps Cancer Center San Diego, California, United States

Northwestern University Chicago, Illinois, United States

The Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

NCT00001444

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Study of Intrathecal Topotecan

NCT00001333

Conditions: Central Nervous System Neoplasms, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

NCT00001748

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

NCT00001302

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +35 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation and Natural History of Children With Cancer and AIDS

NCT00001424

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cancer, +23 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

NCT00001683

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +33 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

NCT00001336

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

NCT00001383

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +35 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies

NCT00001432

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +20 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions